Brain injuries from seizures may persist longer than necessary due to a surprising culprit: ApoE, a protein typically associated with Alzheimer's disease risk. This finding challenges assumptions about how the brain recovers from acute neurological events and suggests new therapeutic targets for seizure aftermath. The research demonstrates that ApoE actively interferes with efferocytosis, the critical process by which microglia clear dead neurons and cellular debris following seizure damage. Specifically, ApoE disrupts the Gas6/MerTK signaling pathway, which normally orchestrates efficient cellular cleanup in brain tissue. When this pathway functions properly, microglia rapidly engulf damaged cells, preventing inflammation and secondary injury. The mouse model revealed that elevated ApoE levels significantly reduced microglial clearance capacity, allowing dead cells and toxic debris to accumulate in seizure-affected brain regions. This impaired cleanup process could explain why some patients experience prolonged neurological symptoms after seizures. The Gas6/MerTK pathway represents a molecular switch that determines whether brain recovery proceeds smoothly or becomes stalled by incomplete debris clearance. This mechanism likely extends beyond seizures to other acute brain injuries where rapid cellular cleanup determines recovery outcomes. The findings are particularly relevant for individuals carrying ApoE4 variants, who may face compounded neurological recovery challenges. While conducted in mice, the research identifies a previously unrecognized role for ApoE in acute brain injury responses, distinct from its established function in chronic neurodegeneration. Understanding this pathway could lead to interventions that enhance microglial function during critical recovery periods, potentially improving outcomes for seizure patients and others with acute neurological injuries.